|
Volumn 40, Issue 14, 1997, Pages 2123-2125
|
(1α,2β,3β,4α)-1,2-Bis[[N-propyl-n-(4-phen oxybenzyl)amino]carbonyl]cyclobutane-3,4-diearboxylic acid (A-87049): A novel potent squalene synthase inhibitor
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1ALPHA,2BETA BIS[[N PROPYL N (4 PHENOXYBENZYL)AMINO]CARBONYL] 3BETA,4ALPHA CYCLOBUTANEDICARBOXYLIC ACID;
1ALPHA,2BETA BIS[[N PROPYL N (4 PHENOXYBENZYL)AMINO]CARBONYL]CYCLOBUTANE 3BETA,4ALPHA DICARBOXYLIC ACID;
ANTILIPEMIC AGENT;
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
SQUALENE SYNTHASE INHIBITOR;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CONTROLLED STUDY;
DRUG POTENCY;
HYPERCHOLESTEROLEMIA;
LIPID BLOOD LEVEL;
LIVER MICROSOME;
MONKEY;
NONHUMAN;
NOTE;
ORAL DRUG ADMINISTRATION;
RAT;
AMIDES;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
DICARBOXYLIC ACIDS;
ENZYME INHIBITORS;
FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE;
FEMALE;
INDICATORS AND REAGENTS;
LOVASTATIN;
MACACA FASCICULARIS;
MALE;
MOLECULAR STRUCTURE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0030790782
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm970058x Document Type: Note |
Times cited : (16)
|
References (20)
|